Accordingly, rapamycin [80,95], as well as CR and PR [73,80,96], is capable of reducing mTOR activation in tumour cells and reducing cancer incidence and tumour size, probably due to an enhancement of autophagy and a reduction in protein synthesis. Here, MTOR is linked to cancer.